Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists
- 23 February 2002
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 438 (3) , 159-170
- https://doi.org/10.1016/s0014-2999(02)01341-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Differential vasoconstrictor activity of human urotensin‐II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkeyBritish Journal of Pharmacology, 2000
- Orphan‐receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin‐1British Journal of Pharmacology, 2000
- Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteriesBritish Journal of Pharmacology, 2000
- Somatostatin‐induced control of cytosolic free calcium in pituitary tumour cellsBritish Journal of Pharmacology, 2000
- Mechanisms involved in the somatostatin-induced contraction of vascular smooth muscle cells☆Peptides, 1999
- Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14Biochemical and Biophysical Research Communications, 1999
- Highly Potent Cyclic Disulfide Antagonists of SomatostatinJournal of Medicinal Chemistry, 1999
- Role of Tyrosine Kinases in Norepinephrine-Induced Contraction of Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1995
- Tyrosine Kinase Inhibitors Suppress Agonist-Induced Contraction in Smooth MuscleBiochemical and Biophysical Research Communications, 1993
- Recognition by goby intestine of a somatostatin analog, SMS 201-995Journal of Experimental Zoology, 1990